Leukemia & Lymphoma
Volume 63, 2022 - Issue 14
Original Articles
Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study
Burhan Ferhanoglua Division of Hematology, Department of Internal Medicine, Koç University School of Medicine, Istanbul, TurkeyCorrespondence[email protected]
https://orcid.org/0000-0002-4257-549XView further author information
https://orcid.org/0000-0002-4257-549XView further author information, , Amado Kardussc Bone Marrow Transplant Program, Instituto de Cancerologia, Clínica las Américas, Medellín, Colombiahttps://orcid.org/0000-0001-8372-102XView further author information
https://orcid.org/0000-0001-8372-102XView further author information, , , , , , , Yok Lam Kwongk Bone Marrow Transplant Unit, Queen Mary Hospital, Hong Kong, China;l Hematology Division, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Hong Kong, Chinahttps://orcid.org/0000-0001-8156-6978View further author information
https://orcid.org/0000-0001-8156-6978View further author information, , , Arif Abdillaho Takeda Pharmaceuticals International AG–Singapore Branch, Singapore, Singaporehttps://orcid.org/0000-0001-6466-9051View further author information
https://orcid.org/0000-0001-6466-9051View further author information, , Mehul Dalalp Takeda R&D Data Sciences Institute, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USAhttps://orcid.org/0000-0002-7417-0817View further author information
https://orcid.org/0000-0002-7417-0817View further author information, & show all